Document Detail


Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.
MedLine Citation:
PMID:  19679693     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: Pulmonary arterial hypertension is associated with impaired exercise capacity and decreased survival in patients with scleroderma. Randomized controlled studies showed significant benefit of targeted therapies in patients with a resting mean pulmonary arterial pressure (MPAP) greater than 25 mm Hg. The clinical relevance of pulmonary arterial pressure values in the upper normal range is unknown. OBJECTIVES: To examine the clinical relevance of pulmonary arterial pressure in scleroderma patients. METHODS: After a noninvasive screening program, 29 patients with systemic sclerosis without significant lung fibrosis and without known pulmonary arterial hypertension underwent right heart catheterization and simultaneous cardiopulmonary exercise test. A six-minute walk distance (6MWD) was determined within 48 hours. MEASUREMENTS AND MAIN RESULTS: A resting MPAP above the median (17 mm Hg) was associated with decreased 6MWD (396 +/- 71 vs. 488 +/- 76 m; P < 0.005) and peak Vo(2) (76 +/- 11% vs. 90 +/- 24%; P = 0.05). Resting pulmonary vascular resistance was inversely correlated with 6MWD (r = 0.45; P < 0.05). At 25 and 50W, MPAP above the median (23 and 28 mm Hg) was associated with decreased 6MWD (P < 0.005; P < 0.0005). At peak exercise, MPAP showed no association with 6MWD or peak Vo(2); however, cardiac index was positively (r = 0.45; P < 0.05) and pulmonary vascular resistance was negatively correlated with 6MWD (r = -0.38; P < 0.05). CONCLUSIONS: MPAP and resistance in the upper normal range at rest and moderate exercise are associated with decreased exercise capacity and may indicate early pulmonary vasculopathy in patients with systemic sclerosis. Investigations on the prognostic and therapeutic implications of such borderline findings are warranted. Clinical trial registered with http://www.clinicaltrials.gov (NCT00609349).
Authors:
Gabor Kovacs; Robert Maier; Elisabeth Aberer; Marianne Brodmann; Stefan Scheidl; Natascha Tröster; Christian Hesse; Wolfgang Salmhofer; Winfried Graninger; Ekkehard Gruenig; Lewis J Rubin; Horst Olschewski
Related Documents :
2703043 - V/q and alveolar gas exchange in pulmonary sarcoidosis.
4076363 - The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas e...
720003 - Propranolol and the ventilatory response to hypoxia and hypercapnia in normal man.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-08-13
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  180     ISSN:  1535-4970     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-21     Completed Date:  2009-12-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  881-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Pulmonology, Medical University Graz, Graz, Austria.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00609349
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure*
Exercise
Exercise Test / methods,  statistics & numerical data
Exercise Tolerance*
Heart Catheterization
Humans
Middle Aged
Rest
Scleroderma, Systemic / physiopathology*
Vascular Resistance
Walking

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in m...
Next Document:  Increasing Proportions of Advanced Pulmonary Tuberculosis Reported in the United States: Are Delays ...